Synapse Medicine provides medication decision solutions to deliver enhanced patient-centered insights for care teams.
Synapse Medicine has raised $28.0M in total funding. The most recent round was Series B. The last funding was announced in February 2022.
Synapse Medicine's investors include Bpifrance, BNP Paribas, Korelya Capital, XAnge, BNP Paribas Développement.
Synapse Medicine is headquartered in Bordeaux, France.
Synapse Medicine provides medication decision solutions to deliver enhanced patient-centered insights for care teams.
Synapse Medicine is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Synapse Medicine — Funding & Investors." VCBacked, February 28, 2022, https://www.vcbacked.co/company/synapse-medicine. Accessed September 30, 2026.
VCBacked. (2022). Synapse Medicine — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/synapse-medicine
{{cite web |title=Synapse Medicine — Funding & Investors |url=https://www.vcbacked.co/company/synapse-medicine |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated